Abstract | BACKGROUND: METHODS: In this prospective multicentre observational study, the clinical outcome of 37 patients with biopsy-proven MN who were negative for PLA2R-Ab and THSD7A-Ab in the serum was analysed. RESULTS: A total of 198 patients were screened for inclusion in the study. Of these, 157 patients were positive for PLA2R-Ab and 4 patients for THSD7A-Ab. The remaining 37 patients were negative for both antibodies were and included in this study. Six patients died during the follow-up, five because of malignant diseases and one of an infection. One patient went into end-stage renal disease, and two patients were lost to follow-up. The remaining 28 patients were followed for at least 24 months (35.6 ± 8.9 months). Seventeen patients received immunosuppressive (IS) therapy, and 11 received supportive care only. At the end of the follow-up, 14 of the 17 patients treated with immunosuppressants and 10 of 11 patients on supportive therapy had a remission of proteinuria. The time to reach remission of proteinuria and serum creatinine levels at the end of the follow-up were not different between both groups. A univariate Cox regression analysis indicated that the use of immunosuppression did not alter the chance to reach a remission of proteinuria. CONCLUSIONS: A high number of PLA2R-Ab- and THSD7A-Ab-negative patients with MN have a good prognosis and might not need IS therapy.
|
Authors | Elion Hoxha, Sigrid Harendza, Hans O Pinnschmidt, Nicola M Tomas, Udo Helmchen, Ulf Panzer, Rolf A K Stahl |
Journal | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
(Nephrol Dial Transplant)
Vol. 30
Issue 11
Pg. 1862-9
(Nov 2015)
ISSN: 1460-2385 [Electronic] England |
PMID | 26142398
(Publication Type: Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't)
|
Copyright | © The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. |
Chemical References |
- Autoantibodies
- Receptors, Phospholipase A2
- THSD7A protein, human
- Thrombospondins
|
Topics |
- Adult
- Aged
- Autoantibodies
(blood)
- Female
- Glomerulonephritis, Membranous
(physiopathology)
- Humans
- Male
- Middle Aged
- Prospective Studies
- Proteinuria
(etiology, physiopathology)
- Receptors, Phospholipase A2
(immunology)
- Remission, Spontaneous
- Thrombospondins
(immunology)
- Treatment Outcome
- Young Adult
|